Welch & Forbes LLC decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 1.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 56,494 shares of the medical instruments supplier’s stock after selling 596 shares during the period. Mettler-Toledo International makes up about 1.0% of Welch & Forbes LLC’s portfolio, making the stock its 29th largest position. Welch & Forbes LLC’s holdings in Mettler-Toledo International were worth $85,360,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of the company. AlphaCore Capital LLC bought a new position in Mettler-Toledo International in the 3rd quarter worth approximately $322,000. Fulcrum Asset Management LLP grew its position in Mettler-Toledo International by 103.1% in the third quarter. Fulcrum Asset Management LLP now owns 6,580 shares of the medical instruments supplier’s stock worth $10,116,000 after acquiring an additional 3,340 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in Mettler-Toledo International by 9.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 951 shares of the medical instruments supplier’s stock valued at $1,409,000 after acquiring an additional 85 shares during the last quarter. Brighton Jones LLC purchased a new stake in Mettler-Toledo International during the third quarter valued at about $243,000. Finally, Ethic Inc. raised its position in Mettler-Toledo International by 14.5% during the third quarter. Ethic Inc. now owns 2,388 shares of the medical instruments supplier’s stock valued at $3,609,000 after purchasing an additional 303 shares in the last quarter. 95.07% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on MTD shares. Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. UBS Group began coverage on shares of Mettler-Toledo International in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 price target for the company. Morgan Stanley raised their price objective on Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 13th. Rothschild & Co Redburn assumed coverage on Mettler-Toledo International in a research note on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price objective on the stock. Finally, Jefferies Financial Group lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Six equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $1,595.77.
Read Our Latest Report on Mettler-Toledo International
Mettler-Toledo International Stock Performance
Shares of MTD stock opened at $1,762.04 on Tuesday. The firm has a market capitalization of $35.31 billion, a price-to-earnings ratio of 38.40, a PEG ratio of 3.47 and a beta of 1.16. The stock has a fifty day moving average of $1,531.95 and a 200 day moving average of $1,347.54. Mettler-Toledo International, Inc. has a 52 week low of $1,023.05 and a 52 week high of $1,806.58. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share for the quarter, beating the consensus estimate of $12.13 by $0.44. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%. The company had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same period in the previous year, the company posted $11.15 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. As a group, research analysts expect that Mettler-Toledo International, Inc. will post 47.49 earnings per share for the current year.
Insider Buying and Selling at Mettler-Toledo International
In other news, CEO Patrick Kaltenbach sold 942 shares of the business’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the completion of the transaction, the chief executive officer owned 4,480 shares in the company, valued at $6,384,000. The trade was a 17.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.71% of the stock is owned by company insiders.
More Mettler-Toledo International News
Here are the key news stories impacting Mettler-Toledo International this week:
- Positive Sentiment: Stifel Nicolaus raised its target from $1,600 to $1,900 and upgraded its rating to “buy,” implying about 7.8% upside. Stifel analyst recommendations
- Positive Sentiment: Barclays lifted its target from $1,700 to $1,900 and maintained an “overweight” rating, also indicating roughly 7.8% upside. Barclays analyst recommendations
- Positive Sentiment: Robert W. Baird raised its target from $1,608 to $1,815, while keeping a “neutral” rating; the revised target suggests modest upside. Baird analyst recommendations
- Neutral Sentiment: JPMorgan raised its target from $1,550 to $1,725 but retained a “neutral” rating; that target is below the quoted share price. JPMorgan analyst recommendations
- Negative Sentiment: Goldman Sachs increased its target from $1,510 to $1,640, but the new target remains below the quoted share price, suggesting limited near-term upside under its valuation. Goldman Sachs target update
About Mettler-Toledo International
Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.
The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.
Recommended Stories
- Five stocks we like better than Mettler-Toledo International
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
